124 related articles for article (PubMed ID: 25143570)
21. Visual detection of high-risk human papillomavirus genotypes 16, 18, 45, 52, and 58 by loop-mediated isothermal amplification with hydroxynaphthol blue dye.
Luo L; Nie K; Yang MJ; Wang M; Li J; Zhang C; Liu HT; Ma XJ
J Clin Microbiol; 2011 Oct; 49(10):3545-50. PubMed ID: 21865423
[TBL] [Abstract][Full Text] [Related]
22. Development and validation of a HPV-32 specific PCR assay.
Herrel NR; Johnson NL; Cameron JE; Leigh J; Hagensee ME
Virol J; 2009 Jun; 6():90. PubMed ID: 19558697
[TBL] [Abstract][Full Text] [Related]
23. The original SPF10 LiPA25 algorithm is more sensitive and suitable for epidemiologic HPV research than the SPF10 INNO-LiPA Extra.
Geraets DT; Struijk L; Kleter B; Molijn A; van Doorn LJ; Quint WG; Colau B
J Virol Methods; 2015 Apr; 215-216():22-9. PubMed ID: 25698462
[TBL] [Abstract][Full Text] [Related]
24. High-throughput two-step LNA real time PCR assay for the quantitative detection and genotyping of HPV prognostic-risk groups.
Leo E; Venturoli S; Cricca M; Musiani M; Zerbini M
J Clin Virol; 2009 Aug; 45(4):304-10. PubMed ID: 19473874
[TBL] [Abstract][Full Text] [Related]
25. Abundance of multiple high-risk human papillomavirus (HPV) infections found in cervical cells analyzed by use of an ultrasensitive HPV genotyping assay.
Schmitt M; Dondog B; Waterboer T; Pawlita M; Tommasino M; Gheit T
J Clin Microbiol; 2010 Jan; 48(1):143-9. PubMed ID: 19864475
[TBL] [Abstract][Full Text] [Related]
26. HPV 9G DNA chip: 100% clinical sensitivity and specificity.
An H; Song KS; Nimse SB; Kim J; Nguyen VT; Ta VT; Sayyed DR; Kim T
J Clin Microbiol; 2012 Mar; 50(3):562-8. PubMed ID: 22170909
[TBL] [Abstract][Full Text] [Related]
27. Human Papillomavirus (HPV) Genotyping Assay Suitable for Monitoring the Impact of the 9-Valent HPV Vaccine.
Kukimoto I; Matsumoto K; Takahashi F; Iwata T; Tanaka K; Yamaguchi-Naka M; Yamamoto K; Yahata H; Nakabayashi M; Kato H; Tsuda N; Onuki M; Yaegashi N;
Tohoku J Exp Med; 2020 Aug; 251(4):287-294. PubMed ID: 32759554
[TBL] [Abstract][Full Text] [Related]
28. Development of a novel liquid bead array human papillomavirus genotyping assay (PGMY-LX) and comparison with linear array for continuity in longitudinal cohort studies.
Farhat S; Scott ME; Ma Y; Moscicki AB
J Clin Microbiol; 2015 Apr; 53(4):1270-6. PubMed ID: 25653406
[TBL] [Abstract][Full Text] [Related]
29. Nested PCR with the PGMY09/11 and GP5(+)/6(+) primer sets improves detection of HPV DNA in cervical samples.
Fuessel Haws AL; He Q; Rady PL; Zhang L; Grady J; Hughes TK; Stisser K; Konig R; Tyring SK
J Virol Methods; 2004 Dec; 122(1):87-93. PubMed ID: 15488625
[TBL] [Abstract][Full Text] [Related]
30. MassARRAY spectrometry is more sensitive than PreTect HPV-Proofer and consensus PCR for type-specific detection of high-risk oncogenic human papillomavirus genotypes in cervical cancer.
Basu P; Chandna P; Bamezai RN; Siddiqi M; Saranath D; Lear A; Ratnam S
J Clin Microbiol; 2011 Oct; 49(10):3537-44. PubMed ID: 21813716
[TBL] [Abstract][Full Text] [Related]
31. Comparison of Two Widely Used Human Papillomavirus Detection and Genotyping Methods, GP5+/6+-Based PCR Followed by Reverse Line Blot Hybridization and Multiplex Type-Specific E7-Based PCR.
Clifford GM; Vaccarella S; Franceschi S; Tenet V; Umulisa MC; Tshomo U; Dondog B; Vorsters A; Tommasino M; Heideman DA; Snijders PJ; Gheit T
J Clin Microbiol; 2016 Aug; 54(8):2031-8. PubMed ID: 27225411
[TBL] [Abstract][Full Text] [Related]
32. Comparative evaluation of AMPLICOR HPV PCR and Linear Array assays on SurePath liquid-based Pap samples for the detection of high-risk HPV genotypes.
Chernesky M; Jang D; Portillo E; Smieja M; Chong S; Buracond S; Klingel M; El Sebai R; Kapala J; Patel J; Biers K; Harroun N; Doucette C; Sumner J
J Clin Virol; 2011 Mar; 50(3):201-4. PubMed ID: 21195020
[TBL] [Abstract][Full Text] [Related]
33. Clinical validation of the HPV-risk assay, a novel real-time PCR assay for detection of high-risk human papillomavirus DNA by targeting the E7 region.
Hesselink AT; Berkhof J; van der Salm ML; van Splunter AP; Geelen TH; van Kemenade FJ; Bleeker MG; Heideman DA
J Clin Microbiol; 2014 Mar; 52(3):890-6. PubMed ID: 24391196
[TBL] [Abstract][Full Text] [Related]
34. Human papillomavirus genotyping by Linear Array and Next-Generation Sequencing in cervical samples from Western Mexico.
Flores-Miramontes MG; Torres-Reyes LA; Alvarado-Ruíz L; Romero-Martínez SA; Ramírez-Rodríguez V; Balderas-Peña LM; Vallejo-Ruíz V; Piña-Sánchez P; Cortés-Gutiérrez EI; Jave-Suárez LF; Aguilar-Lemarroy A
Virol J; 2015 Oct; 12():161. PubMed ID: 26444975
[TBL] [Abstract][Full Text] [Related]
35. Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework.
Oštrbenk A; Xu L; Arbyn M; Poljak M
J Clin Microbiol; 2018 Nov; 56(11):. PubMed ID: 30209184
[TBL] [Abstract][Full Text] [Related]
36. Accurate human papillomavirus genotyping by 454 pyrosequencing.
Militello V; Lavezzo E; Costanzi G; Franchin E; Di Camillo B; Toppo S; Palù G; Barzon L
Clin Microbiol Infect; 2013 Oct; 19(10):E428-34. PubMed ID: 23573945
[TBL] [Abstract][Full Text] [Related]
37. FRET-based detection and genotyping of HPV-6 and HPV-11 causing recurrent respiratory papillomatosis.
Combrinck CE; Seedat RY; Burt FJ
J Virol Methods; 2013 May; 189(2):271-6. PubMed ID: 23473839
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of a new DNA test for detection of carcinogenic human papillomavirus.
Castle PE; Gutierrez EC; Leitch SV; Maus CE; McMillian RA; Nussbaumer WA; Vaughan LM; Wheeler CM; Gravitt PE; Schiffman M
J Clin Microbiol; 2011 Aug; 49(8):3029-32. PubMed ID: 21632892
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of a liquid bead array system for high-risk human papillomavirus detection and genotyping in comparison with Hybrid Capture II, DNA chip and sequencing methods.
Cho EJ; Do JH; Kim YS; Bae S; Ahn WS
J Med Microbiol; 2011 Feb; 60(Pt 2):162-171. PubMed ID: 20965919
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the f-HPV typing™ and Hybrid Capture II® assays for detection of high-risk HPV genotypes in cervical samples.
Cañadas MP; Cirigliano V; Darwich L; Sirera G; Coll J; Clotet B; Videla S
J Virol Methods; 2012 Jul; 183(1):14-8. PubMed ID: 22449759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
